Scheme

ICICI Prudential Nifty Pharma Index Fund

Holds 20 companies worth ₹163 Cr in Sept 2026.

  • Fund house

    ICICIThe fund house that runs this scheme.
  • AUM

    ₹163 CrICICI Prudential Nifty Pharma Index Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 4.0% on Aug 2026, ₹157 Cr.
  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 19.5% of this scheme's NAV.
  • Fund manager

    Venus AhujaRuns it since 1 Nov 2025, as the fund house dates it. With Nishit Patel (co-manager), Ashwini Bharucha (co-manager).

AUM(Dec 2022 – Sept 2026)

AUM at month end each month, and its change on the month before
12 months₹ CrChange
Sept 2026163+4.0%
Aug 2026157+6.0%
Jul 2026148+8.8%
Jun 2026136+4.7%
May 2026130+14.5%
Apr 2026113+8.4%
Mar 2026105+8.3%
Feb 202696.7+4.8%
Jan 202692.3−2.2%
Dec 202594.4−0.9%
Nov 202595.2+4.9%
Oct 202590.8+3.1%
AUM at month end, Sept 2026
₹163 Cr
+79.6% since Oct 2025
Fig. 1.AUM at each month's end, ₹ crore; under All, the quarterly average since 2010. Source: AMFI.

Direct plans(Dec 2022 – Sept 2026)

Direct plans' share of AUM each quarter, and its change on the quarter before
4 quartersShareChange
Sept 202669.24%−0.22 pt
Jun 202669.46%−1.73 pt
Mar 202671.19%+0.72 pt
Dec 202570.47%+1.75 pt
Direct plans' share of AUM, Sept 2026
69.24%
−1.23 pt since Dec 2025
Fig. 2.ICICI Prudential Nifty Pharma Index Fund's quarterly average AUM in direct plans, which pay no distributor; changes in points. Source: AMFI.

Returns(9 Oct 2026)

Growth · Direct and Regular plans

To 9 Oct 2026; past a year, a yearly rate. Benchmark: Nifty Pharma TRI. * From NAVs. Source: AMFI. Click a column's header to sort by it.
1 month *
−2.76%−2.81%––−4.10%
3 months *
+1.28%+1.11%––−3.57%
6 months *
+17.42%+17.02%––+2.05%
1 year
+18.48%+17.71%+19.06%−0.58 pt−0.35%
3 years
+19.84%+19.09%+20.56%−0.73 pt+7.62%
Since launch
+20.04%+19.28%+21.01%−0.97 pt+7.28%
Fig. 3.To 9 Oct 2026; past a year, a yearly rate. Benchmark: Nifty Pharma TRI. * From NAVs. Source: AMFI.